Larimar Therapeutics LRMR
NASDAQ LRMR
$2.96 -0.10 (-3.27%)
At close: Oct 2, 2026 · 4:00 PM EDT

Larimar Therapeutics (LRMR) Interest & Investment Income (2014 - 2020)

Updated

Larimar Therapeutics (LRMR) posted Interest & Investment Income of $258,000 for Q1 2020, down 59.8% from $642,000 a year earlier and down 23.0% from the prior quarter.

Analysis

Larimar Therapeutics (LRMR) Interest & Investment Income (2014 - 2020) Analysis & Trends

For the trailing twelve months through Mar 31, 2020, Interest & Investment Income at Larimar Therapeutics was $1.61 million, down 29.1% year-over-year; for FY2019, it was $1.99 million, up 5.3% from FY2018.

  • Annual Interest & Investment Income has increased for four consecutive years, with a five-year compound annual growth rate of 134.6% (FY2014 to FY2019).
  • In prior years, Larimar Therapeutics' Interest & Investment Income was $1.89 million in FY2018 (+89.7%), $996,000 in FY2017 (+11.4%), $894,000 in FY2016 (+104.1%) and $438,000 in FY2015.
  • The Q1 2020 figure stands as the lowest quarterly Interest & Investment Income since Q4 2017.
  • On a year-over-year basis, Interest & Investment Income has declined in each of the last three quarters, with growth averaging 50.6% over the last eight quarters.
  • The strongest year-over-year quarter for Interest & Investment Income in the past five years was Q4 2015, with growth of 642.3%; the weakest was Q1 2020, with a decline of 59.8%.
  • According to Business Quant data, Interest & Investment Income for the three prior quarters was $335,000 (Q4 2019), $451,000 (Q3 2019) and $561,000 (Q2 2019).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Int & Inv Inc (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn -
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn 219.00 Mn
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn -
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn -
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn -
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn 80.00 Mn
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn -
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn -
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn -
10 Larimar Therapeutics 307.49 Mn -299.58 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2020 258,000.00
Dec 31, 2019 335,000.00
Sep 30, 2019 451,000.00
Jun 30, 2019 561,000.00
Mar 31, 2019 642,000.00
Dec 31, 2018 675,000.00
Sep 30, 2018 623,000.00
Jun 30, 2018 324,000.00
Mar 31, 2018 267,000.00
Dec 31, 2017 256,000.00
Sep 30, 2017 266,000.00
Jun 30, 2017 247,000.00
Mar 31, 2017 227,000.00
Dec 31, 2016 230,000.00
Sep 30, 2016 230,000.00
Jun 30, 2016 225,000.00
Mar 31, 2016 209,000.00
Dec 31, 2015 193,000.00
Sep 30, 2015 143,000.00
Jun 30, 2015 63,000.00
API Access

Larimar Therapeutics Interest & Investment Income API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=interest-and-investment-income&ticker=LRMR&period=max&api_key=YOUR_API_KEY